Introduction: This study aimed to screen immune-related marker genes of ischemic stroke (IS).

Material And Methods: Two IS-related gene expression datasets were downloaded. The significantly differentially expressed genes (DEGs) and miRNAs (DEMs) between IS and control groups were selected. The differential immune cells were analysed. Weighted gene co-expression network analysis (WGCNA) was applied to analyse immune-related genes, followed by function analysis and interaction network construction. Then, key genes were further screened using optimization algorithm to construct a diagnostic model. Finally, miRNA regulatory network of several key genes was established.

Results: In total 321 DEGs and 140 DEMs were obtained. 11 immune cell types were significantly different between IS and control groups. WGCNA identified two key modules, involving 202 differential immune genes. The greenyellow module was enriched in biological processes and pathways associated with T cells, while the midnightblue module was mainly associated with apoptosis, and inflammatory response-related functions and pathways. Protein interaction network identified 10 hub nodes, such as CD8A, ITGAM and TLR4. LASSO regression selected 8 key feature genes, and a risk score model was established. Key model genes were enriched in 63 GO biological processes, such as microglial cell activation, and B cell apoptotic process, and 3 KEGG pathways, such as negative regulation of nuclear cell cycle DNA replication, and hematopoietic cell lineage. Finally, a total of 25 miRNA-target relationship pairs were obtained.

Conclusions: This study identified some immune-related marker genes and constructed a diagnostic model based on 8 immune-related genes in IS.

Download full-text PDF

Source
http://dx.doi.org/10.5114/fn.2024.135846DOI Listing

Publication Analysis

Top Keywords

diagnostic model
12
immune-related genes
12
genes
11
ischemic stroke
8
based immune-related
8
immune-related marker
8
marker genes
8
control groups
8
differential immune
8
interaction network
8

Similar Publications

Microkinetic modeling of heterogeneous catalysis serves as an efficient tool bridging atom-scale first-principles calculations and macroscale industrial reactor simulations. Fundamental understanding of the microkinetic mechanism relies on a combination of experimental and theoretical studies. This Perspective presents an overview of the latest progress of experimental and microkinetic modeling approaches applied to gas-solid catalytic kinetics.

View Article and Find Full Text PDF

Objective: Around 30% of people with schizophrenia are refractory to antipsychotic treatment (treatment-resistant schizophrenia). Abnormal structural neuroimaging findings, in particular volume and thickness reductions, are often described in schizophrenia. Novel biomarkers of active brain pathology such as neurofilament light chain protein are now expected to improve current understanding of psychiatric disorders, including schizophrenia.

View Article and Find Full Text PDF

Background: Bone marrow examination (BME) is the gold standard of diagnosing myelodysplastic syndromes (MDS).

Problems: it is invasive, painful, causing possible bleeding, inaccurate (aspirate hemodilution), and subjective (inter-observer interpretation discordance). We developed non-invasive diagnostic tools: A logistic regression formula [LeukRes 2018], then a web algorithm using 10 variables (age, gender, Hb, MCV, WBC, ANC, monocytes, PLT, glucose, creatinine) to diagnose/exclude MDS [BldAdv 2021].

View Article and Find Full Text PDF

Initiation of Psychotropic Drugs in Spouses of Patients With Early-Onset Alzheimer's Disease: A Matched Cohort Study.

Int J Geriatr Psychiatry

January 2025

Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan.

Objectives: The diagnosis of early-onset Alzheimer's disease (EOAD) can cause emotional stress not only to the patients themselves but also to their spouses. This study aimed to evaluate the risk of psychiatric disorders in spouses of EOAD patients, using psychotropic drug initiation as a surrogate indicator.

Methods: A cohort study was conducted using a Japanese claims database, with spouses of EOAD patients (exposed spouses) matched with spouses of non-EOAD individuals (reference spouses) up to a 1:10 ratio.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!